Warner Chilcott UK Limited - search results

alembic pharmaceuticals limited - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 10 mg - fluoxetine is indicated for the treatment of: · acute and maintenance treatment of major depressive disorder [see clinical studies (14.1)] . · acute and maintenance treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd) [see clinical studies (14.2)]. · acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa [see clinical studies (14.3)] . · acute treatment of panic disorder, with or without agoraphobia [see clinical studies (14.4)]. fluoxetine and olanzapine in combination is indicated for the treatment of: · acute treatment of depressive episodes associated with bipolar i disorder in adult. fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar i disorder or the treatment of treatment resistant depression. when using fluoxetine and olanzapine in combination, also refer to the clinical studies section of the package

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nitrofurantoin 50mg capsules

morningside healthcare ltd - nitrofurantoin - oral capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nitrofurantoin 100mg capsules

morningside healthcare ltd - nitrofurantoin - oral capsule - 100mg